Rocco Valerio Viola

TL;DR: The selected miRNAs presented high accuracy in discriminating SCD from AMI (miR‐1 and miR‐499) and AMI from control (mi R‐208) representing a potential aid for both clinicians and pathologists for differential diagnosis.

TL;DR: Investigating the pathology and degree of clinical diagnosis and treatment strategies, the animal models that have allowed us to better understand this entity and the role of new diagnostic and prognostic tools such as miRNA could improve the ability to manage this pathological entity.

TL;DR: PMCTA demonstrated a high accuracy in the diagnosis of parietal and luminal coronary changes but was less effective in detecting myocardial ischemia and necrosis, suggesting that PMCTA can improve the performance of the autopsy.

TL;DR: Early-induced molecules driven by hypoxia, as chaperonins HSPs and ORP150, besides common markers for inflammatory responses, have predictive value in timing the onset of neonatal hypoxic-ischemic injury; on the other hand, clinical biomarkers for HII diagnosis, as CK-BB, LDH, S-100beta, and NSE, could be useful to predict outcomes.

TL;DR: Some antigens expressed on leukocyte surfaces, endothelial markers and junctions, and soluble factors showed potential reliability in differentiating sepsis cases from controls and further studies are needed to provide a concrete validation for a combination of markers on specific organ samples.